We are live on
!
Find out more
UOC
UBS O'Connor Portfolio holdings
AUM
$3.76B
1-Year Est. Return
62.41%
This Fund
S&P 500
This Quarter
Est. Return
+4.17%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$10.3B
AUM Growth
+$4.59B
(+80%)
Cap. Flow
+$3.41B
Cap. Flow
% of AUM
32.95%
Top 10 Holdings %
Top 10 Hldgs %
18.2%
Holding
970
New
347
Increased
294
Reduced
63
Closed
219
Avg Time Held Equity + Options
1.3
quarters
Top 10 Avg Time Held Equity + Options
1
quarter
Top 20 Avg Time Held Equity + Options
1.6
quarters
Avg Time Held Equity only
1.3
quarters
Top 10 Avg Time Held Equity only
1
quarter
Top 20 Avg Time Held Equity only
1.6
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SLXP
SALIX PHARMACEUTICALS LTD DEL
SLXP
|
+$230M |
| 2 |
NLSN
Nielsen Holdings plc
NLSN
|
+$110M |
| 3 |
Brightstar Lottery PLC
BRSL
|
+$98M |
| 4 |
FDO
FAMILY DOLLAR STORES
FDO
|
+$96.8M |
| 5 |
GE Aerospace
GE
|
+$92.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$142M |
| 2 |
PROTECTIVE LIFE CORP
PL
|
+$135M |
| 3 |
CFN
CAREFUSION CORPORATION
CFN
|
+$129M |
| 4 |
AGN
Allergan Inc
AGN
|
+$97.8M |
| 5 |
CVD
COVANCE INC.
CVD
|
+$84.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 20.85% |
| 2 | Industrials | 15.86% |
| 3 | Consumer Discretionary | 15.68% |
| 4 | Consumer Staples | 11.68% |
| 5 | Technology | 8.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
776
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$27.6B
| – | – |
-20,000
| Closed | -$2.39M | – |
|
777
Landstar System
LSTR
$5.74B
| – | – |
-4,734
| Closed | -$343K | – |
|
778
Macerich
MAC
$6.31B
| – | – |
-3,868
| Closed | -$338K | – |
|
779
ManpowerGroup
MAN
$2.45B
| – | – |
-5,320
| Closed | -$363K | – |
|
780
CALL
Madrigal Pharmaceuticals
MDGL
$10.9B
| – | – |
-714
| Closed | -$1K | – |
|
781
Lite Strategy Inc
LITS
$38.6M
| – | – |
-3,355
| Closed | -$287K | – |
|
782
Methanex
MEOH
$4.8B
| – | – |
-118,800
| Closed | -$5.45M | – |
|
783
McCormick & Company Non-Voting
MKC
$12.1B
| – | – |
-63,916
| Closed | -$2.37M | – |
|
784
PUT
Altria Group
MO
$120B
| – | – |
-150,800
| Closed | -$241K | – |
|
785
Marathon Petroleum
MPC
$128B
| – | – |
-9,344
| Closed | -$422K | – |
|
786
Marvell Technology
MRVL
$247B
| – | – |
-30,804
| Closed | -$447K | – |
|
787
Morgan Stanley
MS
$298B
| – | – |
-108,874
| Closed | -$4.22M | – |
|
788
Vail Resorts
MTN
$5.2B
| – | – |
-5,480
| Closed | -$499K | – |
|
789
National Fuel Gas
NFG
$7.48B
| – | – |
-3,776
| Closed | -$263K | – |
|
790
NOV
NOV
$6.76B
| – | – |
-432,792
| Closed | -$28.4M | – |
|
791
Nucor
NUE
$56.8B
| – | – |
-578,856
| Closed | -$28.4M | – |
|
792
Novavax
NVAX
$2.1B
| – | – |
-1,170
| Closed | -$139K | – |
|
793
Ocugen
OCGN
$324M
| – | – |
-417
| Closed | -$275K | – |
|
794
OGE Energy
OGE
$9.61B
| – | – |
-7,509
| Closed | -$266K | – |
|
795
Oceaneering
OII
$4.46B
| – | – |
-249,864
| Closed | -$14.7M | – |
|
796
Olin
OLN
$1.7B
| – | – |
-21,538
| Closed | -$490K | – |
|
797
Otter Tail
OTTR
$3.67B
| – | – |
-6,865
| Closed | -$213K | – |
|
798
DELISTED
Paramount Global Class B
PARA
| – | – |
-232,253
| Closed | -$12.9M | – |
|
799
Pitney Bowes
PBI
$2.3B
| – | – |
-14,375
| Closed | -$350K | – |
|
800
Petrobras Class A
PBR.A
$145B
| – | – |
-150,000
| Closed | -$1.14M | – |
|
Similar funds
FNBT
ACI
RC
A
CGL
CB
JCM
MPM
UBS O'Connor's Q1 2015 Portfolio in Review
As of Q1 2015, UBS O'Connor held 970 positions worth $10.3B, up 80% from $5.75B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
UBS O'Connor deployed $3.41B of net new capital in Q1 2015, opening 347 new positions and adding to 294 existing holdings. Its largest new stake was SALIX PHARMACEUTICALS LTD DEL: 1,567,292 shares worth $271M.
By sector, the portfolio is most concentrated in Miscellaneous at 21% of assets, down from 21% a quarter earlier, followed by Industrials and Consumer Discretionary.
On the sell side, the largest reduction was Humana, an estimated $57.6M trimmed.
- UBS O'Connor's largest Q1 2015 buy was SALIX PHARMACEUTICALS LTD DEL: 1,567,292 shares worth $271M.
- UBS O'Connor added most to Nielsen Holdings plc in Q1 2015, an estimated $110M increase.
- UBS O'Connor's biggest Q1 2015 reduction was Humana, cutting an estimated $57.6M.
- UBS O'Connor fully exited COVIDIEN PLC COM SHS NEW (IRELAND) in Q1 2015, selling an estimated $142M.
- UBS O'Connor's ten largest holdings make up 18% of its $10.3B portfolio in Q1 2015.
- UBS O'Connor opened 347 new positions and closed 219 in Q1 2015.
- UBS O'Connor's portfolio value rose 80% quarter-over-quarter to $10.3B.
Based on UBS O'Connor's 13F filing for Q1 2015, filed 14 May 2015.